|
1
|
de Mattos AZ, Debes JD, Boonstra A, Yang
JD, Balderramo DC, Sartori GDP and de Mattos AA: Current impact of
viral hepatitis on liver cancer development: The challenge remains.
World J Gastroenterol. 27:3556–3567. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bravi F, Bosetti C, Tavani A, Gallus S and
La Vecchia C: Coffee reduces risk for hepatocellular carcinoma: An
updated meta-analysis. Clin Gastroenterol Hepatol. 11:1413–1421.e1.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tangkijvanich P, Mahachai V, Komolmit P,
Fongsarun J, Theamboonlers A and Poovorawan Y: Hepatitis B virus
genotypes and hepatocellular carcinoma in Thailand. World J
Gastroenterol. 11:2238–2243. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Du Y, Su T, Ding Y and Cao G: Effects of
antiviral therapy on the recurrence of hepatocellular carcinoma
after curative resection or liver transplantation. Hepat Mon.
12(e6031)2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16(94)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
He YX, Ju H, Li N, Jiang YF, Zhao WJ, Song
TT and Ren WH: Association between hsa_circ_0006156 expression and
incidence of gastric cancer. Eur Rev Med Pharmacol Sci.
24:3030–3036. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen KH, Pan JF, Chen ZX, Pan D, Gao T,
Huang M and Huang JN: Effects of hsa_circ_0000711 expression level
on proliferation and apoptosis of hepatoma cells. Eur Rev Med
Pharmacol Sci. 24:4161–4171. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wu C, Deng L, Zhuo H, Chen X, Tan Z, Han
S, Tang J, Qian X and Yao A: Circulating circRNA predicting the
occurrence of hepatocellular carcinoma in patients with HBV
infection. J Cell Mol Med. 24:10216–10222. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang S, Cui S, Zhao W, Qian Z, Liu H, Chen
Y, Lv F and Ding HG: Screening and bioinformatics analysis of
circular RNA expression profiles in hepatitis B-related
hepatocellular carcinoma. Cancer Biomark. 22:631–640.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cortes-Lopez M and Miura P: Emerging
functions of circular RNAs. Yale J Biol Med. 89:527–537.
2016.PubMed/NCBI
|
|
13
|
Barbagallo D, Caponnetto A, Brex D,
Mirabella F, Barbagallo C, Lauretta G, Morrone A, Certo F, Broggi
G, Caltabiano R, et al: CircSMARCA5 regulates VEGFA mRNA splicing
and angiogenesis in glioblastoma multiforme through the binding of
SRSF1. Cancers (Basel). 11(194)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen G, Liu T, Yu B, Wang B and Peng Q:
CircRNA-UBE2G1 regulates LPS-induced osteoarthritis through
miR-373/HIF-1a axis. Cell Cycle. 19:1696–1705. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lu Y, Tan L and Wang X: Circular
HDAC9/microRNA-138/Sirtuin-1 pathway mediates synaptic and amyloid
precursor protein processing deficits in Alzheimer's disease.
Neurosci Bull. 35:877–888. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gu H, Cheng X, Xu J, Zhou K, Bian C, Chen
G and Yin X: Circular RNA circFAT1(e2) promotes osteosarcoma
progression and metastasis by sponging miR-181b and Regulating HK2
Expression. Biomed Res Int. 2020(3589871)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5(R1)2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhao G and Dai GJ: Hsa_circRNA_000166
Promotes cell proliferation, migration and invasion by regulating
miR-330-5p/ELK1 in colon cancer. Onco Targets Ther. 13:5529–5539.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li Y, Shi P, Zheng T, Ying Z and Jiang D:
Circular RNA hsa_circ_0131242 promotes triple-negative breast
cancer progression by sponging hsa-miR-2682. Onco Targets Ther.
13:4791–4798. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lin J, Liao S, Li E, Liu Z, Zheng R, Wu X
and Zeng W: circCYFIP2 acts as a sponge of miR-1205 and affects the
expression of its target gene E2F1 to regulate gastric cancer
metastasis. Mol Ther Nucleic Acids. 21:121–132. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mao Y, Lv M, Cao W, Liu X, Cui J, Wang Y,
Wang Y, Nie G, Liu X and Wang H: Circular RNA 000554 represses
epithelial-mesenchymal transition in breast cancer by regulating
microRNA-182/ZFP36 axis. FASEB J:. 34:11405–11420. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shang A, Gu C, Wang W, Wang X, Sun J, Zeng
B, Chen C, Chang W, Ping Y, Ji P, et al: Exosomal circPACRGL
promotes progression of colorectal cancer via the
miR-142-3p/miR-506-3p- TGF-β1 axis. Mol Cancer.
19(117)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang M, Luo H and Hui L: MiR-3619-5p
hampers proliferation and cisplatin resistance in cutaneous
squamous-cell carcinoma via KPNA4. Biochem Biophys Res Commun.
513:419–425. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang Q, Miao S, Han X, Li C, Zhang M, Cui
K, Xiong T, Chen Z, Wang C and Xu H: MicroRNA-3619-5p suppresses
bladder carcinoma progression by directly targeting beta-catenin
and CDK2 and activating p21. Cell Death Dis. 9(960)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tan A, Li Q and Chen L: CircZFR promotes
hepatocellular carcinoma progression through regulating
miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway. Arch
Biochem Biophys. 661:196–202. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhan M, He K, Xiao J, Liu F, Wang H, Xia
Z, Duan X, Huang R, Li Y, He X, et al: LncRNA HOXA11-AS promotes
hepatocellular carcinoma progression by repressing miR-214-3p. J
Cell Mol Med. 22:3758–3767. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lin T, Dai Y, Guo X, Chen W, Zhao J, Cao L
and Wu Z: Silencing of hsa_circ_0008450 represses hepatocellular
carcinoma progression through regulation of microRNA-214-3p/EZH2
Axis. Cancer Manag Res. 11:9133–9143. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pan H, Tang L, Jiang H, Li X, Wang R, Gao
J and Li Q: Enhanced expression of circ_0000267 in hepatocellular
carcinoma indicates poor prognosis and facilitates cell progression
by sponging miR-646. J Cell Biochem: Feb 5, 2019 (Epub ahead of
print).
|
|
31
|
Huang JL, Ren TY, Cao SW, Zheng SH, Hu XM,
Hu YW, Lin L, Chen J, Zheng L and Wang Q: HBx-related long
non-coding RNA DBH-AS1 promotes cell proliferation and survival by
activating MAPK signaling in hepatocellular carcinoma. Oncotarget.
6:33791–33804. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhao X, Qin W, Jiang Y, Yang Z, Yuan B,
Dai R, Shen H, Chen Y, Fu J and Wang H: ACADL plays a
tumor-suppressor role by targeting Hippo/YAP signaling in
hepatocellular carcinoma. NPJ Precis Oncol. 4(7)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y,
Ma Z and Chen Y: Circular RNA LPAR3 sponges microRNA-198 to
facilitate esophageal cancer migration, invasion, and metastasis.
Cancer Sci. 111:2824–2836. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang X, Chen Y, Liu W, Liu T and Sun D:
Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by
sponging hsa-miR-1184 and releasing AJUBA and inactivating
Hippo/YAP signalling. J Cell Mol Med. 24:9908–9924. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Choi JH, Kim MJ, Park YK, Im JY, Kwon SM,
Kim HC, Woo HG and Wang HJ: Mutations acquired by hepatocellular
carcinoma recurrence give rise to an aggressive phenotype.
Oncotarget. 8:22903–22916. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cao Y, Tao Q, Kao X and Zhu X:
Hsa-circRNA-103809 promotes hepatocellular carcinoma development
via MicroRNA-1270/PLAG1 like zinc finger 2 axis. Dig Dis Sci.
66:1524–1532. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu W, Yin C and Liu Y: Circular RNA
circ_0091579 promotes hepatocellular carcinoma proliferation,
migration, invasion, and glycolysis through miR-490-5p/CASC3 Axis.
Cancer Biother Radiopharm: Jul 14, 2020 (Epub ahead of print).
|
|
38
|
Guerrieri F, Belloni L, D'Andrea D,
Pediconi N, Le Pera L, Testoni B, Scisciani C, Floriot O, Zoulim F,
Tramontano A and Levrero M: Genome-wide identification of direct
HBx genomic targets. BMC Genomics. 18(184)2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Levrero M and Zucman-Rossi J: Mechanisms
of HBV-induced hepatocellular carcinoma. J Hepatol. 64 (Suppl
1):S84–S101. 2016.PubMed/NCBI View Article : Google Scholar
|
